Dexcom (DXCM) reported $4.7B in revenue for fiscal 2025, +15.6% year on year. That ranks #856 by revenue among 2853 SEC filers and #75 in Healthcare. Net income was $836M, a net margin of 17.9%. Revenue has grown 34.1% a year on average since 2011 ($76.3M then). The fiscal 2025 balance sheet shows $6.3B in total assets, $918M in cash and $4.6M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $4.7B | +15.6% | FY20252025-12-31 |
| Gross profitGrossProfit | $2.8B | +14.9% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $912M | +52.0% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $836M | +45.1% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $1.4B | +45.6% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $364M | +1.3% | FY20252025-12-31 |
| Total assetsAssets | $6.3B | −2.2% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $2.7B | +30.6% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $918M | +51.4% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $4.6M | −32.4% | FY20142014-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $1.2B | $200M | Open → |
| Q2 20262026-06-30 | $1.3B | $249M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 27 of 161 companies compared | 17.9% | |
| Operating marginRank 36 of 160 companies compared | 19.6% | |
| R&D as share of revenueRank 40 of 102 companies compared | 12.9% | |
| Cash as share of revenueRank 53 of 160 companies compared | 19.7% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Dexcom Inc
- Ticker
- DXCM
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0001093557
Filings
- 10-QJul 30, 2026Open filing →
- 10-QApr 30, 2026Open filing →
- 10-KFeb 12, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Ensign GroupENSG | $5.1B | $344M |
| HerbalifeHLF | $5.0B | $228M |
| Elanco Animal HealthELAN | $4.7B | −$232M |
| DexcomDXCM | $4.7B | $836M |
| Cno FinancialCNO | $4.5B | $229M |
| Idexx LaboratoriesIDXX | $4.3B | $1.1B |
| Jazz PharmaceuticalsJAZZ | $4.3B | −$356M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Dexcom — Key figures |url=https://companiesranked.com/en/company/dexcom |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Dexcom — Key figures. CompaniesRanked. https://companiesranked.com/en/company/dexcomBibTeX
@misc{companiesranked-en-company-dexcom-2026,
author = {{CompaniesRanked}},
title = {{Dexcom — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/dexcom}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001093557-26-000027 · February 12, 2026
{{cite web |title=Dexcom — Key figures — 10-K (0001093557-26-000027) |url=https://www.sec.gov/Archives/edgar/data/1093557/000109355726000027/dxcm-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-12}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.